The program consisted of key T2 elements deemed vital for attendees and introduced the “match-making” concept of pairing attendees with presenters and technology transfer representatives for one-on-one meetings. Overall the conference continued to meet its mission of providing valuable information about the benefits of technology transfer to those in attendance. To follow are areas that supported the event’s success.
Two-thirds of registrants were familiar with commercializing a product (66% vs 34%). Just under sixty percent of all registrants did have experience with product development, the patent process, and/or research and development. However, two-fifths of registrants were unaware of the overall process in general.
With the Bay Area's global diversity, international connectivity, and high-tech advancements, Oakland is creating it's own reputation and dominating the innovative landscape within FinTech, high-tech, bio-tech, and medical research.
The program and agenda in Oakland focused heavily on start-up and growth stage funding. Present and highlighted laboratories included: Lawrence Berkeley National Laboratory; National Institutes of Health; NASA Armstrong Flight Research Center; Lawrence Livermore National Laboratory; USDA Agricultural Research Service; and UC Merced.
Completed markets on the MBDA InVision Tour are Oakland, CA; Houston, TX; Atlanta, GA
Next markets on the MBDA InVision Tour are New York, NY; Detroit, MI.